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Abstract
Background: Neisseria meningitidis is an inhabitant of the mucosal surfaces of the human nasopharynx. We recently
demonstrated that the secreted meningococcal Two-partner secretion protein A (TpsA) is involved in interbacterial
competition. The C-terminal end of the large TpsA protein contains a small toxic domain that inhibits the growth of
target bacteria. The producing cells are protected from this toxic activity by a small immunity protein that is encoded
by the gene immediately downstream of the tpsA gene. Further downstream on the chromosome, a repertoire of toxic
modules, designated tpsC cassettes, is encoded that could replace the toxic module of TpsA by recombination. Each
tpsC cassette is associated with a gene encoding a cognate immunity protein.
Results: Blast searchers using the toxic domains of TpsA and TpsC proteins as queries identified homologies with the
C-terminal part of neisserial MafB proteins, which, for the rest, showed no sequence similarity to TpsA proteins. On the
chromosome, mafB genes are part of genomic islands, which include cassettes for additional toxic modules as well as
genes putatively encoding immunity proteins. We demonstrate that a MafB protein of strain B16B6 inhibits the
growth of a strain that does not produce the corresponding immunity protein. Assays in E. coli confirmed that
the C-terminal region of MafB is responsible for toxicity, which is inhibited by the cognate immunity protein. Pull-down
assays revealed direct interaction between MafB toxic domains and the cognate immunity proteins.
Conclusions: The meningococcal MafB proteins are novel toxic proteins involved in interbacterial competition.
Keywords: Adhesin, Anti-toxin, Contact-dependent growth inhibition, MafB, Neisseria meningitidis, Toxin, Two-partner
secretion
Background
The cell envelope of Gram-negative bacteria consists of
two membranes, the inner and outer membrane, which
are separated by the periplasm containing a peptidogly-
can layer. Different transport machineries have evolved
for delivering proteins from their site of synthesis in the
cytoplasm to the bacterial surface and beyond. One of
them is the two-partner secretion (TPS) system, which is
broadly used in many Gram negatives for the specific se-
cretion of usually very large proteins, generically called
TpsA [1]. After transport across the inner membrane via
the Sec system, the TpsA protein is translocated across
the outer membrane via a dedicated transporter, called
TpsB. Recognition between the proteins is mediated by
a specific N-terminal domain of ~300 amino acid resi-
dues in TpsA, the TPS domain, which interacts with a
periplasmically exposed domain of the outer-membrane-
embedded TpsB protein [1].
In several microorganisms, including Escherichia coli
and Neisseria meningitidis, TpsA functions in inhibiting
the growth of related bacteria in competition for the
same niche in a process called contact-dependent
growth inhibition (CDI) [2–4]. In the proposed model
[2], the surface-exposed TpsA interacts with a conserved
receptor, BamA, on a target cell, after which a small
C-terminal part of TpsA is proteolytically released and
transported into the target cell in a process that also
requires the inner-membrane protein AcrB [5]. An alter-
native import pathway requires the interaction of the
toxin with the F pilus and pilus retraction [6]. In the tar-
get cell, the toxin, can exert different toxic activities, e.g.
as a DNase or an RNase. The gene immediately down-
stream of tpsA, called tpsI, encodes a small immunity
protein that protects the producing cell against the toxic
activity of the C-terminal domain of TpsA. On the
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chromosome, the tpsB, tpsA and tpsI genes are present
on genetic islands often additionally containing a num-
ber of tpsC cassettes [4]. These tpsC cassettes potentially
encode N-terminally truncated TpsA proteins, which,
however, present an entirely different toxic module at
the C terminus. Each tpsC cassette is associated with a
cognate tpsI gene. Because of the N-terminal truncation,
these putative TpsC proteins lack the sequences neces-
sary for secretion and it is not sure whether they are
expressed. However, the tpsC cassettes can recombine
with the tpsA locus, thereby replacing the toxic module
present at the C terminus of TpsA [4]. Thus, TpsA con-
stitutes an interbacterial competition system that can
use a broad repertoire of toxic modules.
Other secretion systems found in Gram-negative bacteria
are also meant for inhibiting competing bacteria or even
eukaryotic cells. Examples include RhsA (rearrangement
hot spot) of E. coli [7] or the broadly distributed Type VI
secretion system [8]. These growth inhibition systems
present similar toxic modules at the C terminus of the
exported proteins as found in the TpsA proteins, but show
no further sequence similarity with TpsA, consistent with a
different secretion mechanism. In the present study, we
demonstrate that the MafB proteins of Neisseria spp., pre-
viously thought to function as adhesins [9], present similar
toxic modules at their C terminus as the TpsA proteins,
but show no further sequence similarity to TpsA. We dem-
onstrate that these MafB proteins represent a novel growth
inhibition system in the meningococcal strain B16B6 that
functions in interbacterial competition. Whilst this manu-
script was in preparation, another study of the MafB
proteins of Neisseria spp. was published [10]. For clarity,
we have adopted the nomenclature for the Maf proteins of
that study.
Results
Structural organization of meningococcal Maf islands
BLAST searches using different toxic domains of various
meningococcal TpsA and TpsC sequences as queries
yielded hits with various TpsAs and TpsCs of different
bacterial species. Additional hits were also retrieved with
the C termini from a large variety of other proteins,
including neisserial MafB proteins. MafB proteins are
present in different Neisseria spp., including N. meningi-
tidis, N. lactamica and N. gonorrhoeae, and they were
earlier assigned as members of a multiple adhesin family
of proteins thought to be involved in adhesion to host
cells [9]. The sequence similarity of MafB with TpsAs or
TpsCs is restricted to the C-terminal toxic module, indi-
cating that MafB is not secreted via a TPS mechanism.
Inspection of its genetic context in available genome
sequences indicated that the mafB genes are compo-
nents of genetic islands. The genes in the islands may
form an operon composed, from 5’ to 3’ end, of mafA,
mafB and a variable number of mafB-related genes, po-
tentially encoding alternative C-terminal domains and
designated mafB-CT. These mafB and mafB-CT genes
are interspersed with one or more intervenient ORFs,
which may encode immunity proteins (designated mafI)
(see Fig. 1 for examples). Up to three independent maf
genetic islands, present on different chromosomal loca-
tions, can be recognized in meningococcal genomes
(Fig. 1), designated MGI-1, 2, and 3 according to a re-
cent proposal [10]. The predicted MafA proteins con-
tain a lipoprotein signal sequence, and phylogenetic
analysis of MafA proteins from different strains of vari-
ous Neisseria spp. revealed clustering of the sequences
in two phylogenetic groups (Fig. 2) with > 95 % of iden-
tity within each group and < 70 % identity between
groups. MafB proteins contain a predicted N-terminal
signal sequence, and the mature part is further structured
into three regions: an N-terminal DUF1020 domain of
~ 260–320 aa in length, a central region of ~140 aa con-
taining a Hint domain, which is usually involved in auto-
catalytic protein splicing, and a variable C-terminal toxic
domain of ~80-100 aa. The N-terminal DUF1020 domains
of MafB proteins can be clustered in three variants, I, II
and III, where variants I and II are phylogenetically more
related (Fig. 2). The central region is conserved in se-
quence, but its presence is variable as some MafBs lack
the Hint domain. The C-terminal region is polymorphic
and constitutes an independent toxic domain. The mafB-
CTs are variable in length (260–893 bp). At their 3’ end,
they contain sequences that putatively encode a toxic do-
main, whilst upstream thereof they share sequence simi-
larity with sequences adjacent to the toxic region of mafB
genes, including sometimes an intact Hint domain. Some
mafB-CTs, for instance NMBG2136_0586 of strain G2136
(Fig. 1), encode a VENN domain previously recognized as
being adjacent to the toxin domain in TpsA proteins [2].
The mafB-CT genes generally lack sequences correspond-
ing to the 5´ end of mafB genes, but occasionally, a
complete mafB is found among the mafB-CT genes, for
example NMO_0056 or NMC2090 in MGI-3 of strains
Alpha14 and FAM18, respectively (Fig. 1). The shared se-
quences between mafB and mafB-CT genes may be used
for genetic rearrangements, resulting in the substitution of
the toxic domain at the C terminus of MafB. Examination
of various neisserial genome sequences suggests that such
recombination events have indeed occurred in several
cases, since the C-terminal domains of some MafB pro-
teins have > 95 % of sequence similarity with predicted
MafB-CT proteins from other genomes. For example, the
3’ end of mafB-CT NMBG2136_0598 in MGI-2 of G2136
is placed at the 3’ end of the mafB NMC1790 in MGI-1 of
strain FAM18 (Fig. 1). In general, such rearrangements
also affect the position of the immediately downstream lo-
cated mafI gene, which remains associated with the 3’ end
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of the upstream mafB or mafB-CT gene, supporting the
notion that these modules function as specific toxin-
antitoxin pairs. However, in some islands, several mafIs
are associated with a specific mafB or mafB-CT (Fig. 1); it
is not clear whether they are all required to confer im-
munity against the toxic domain of the corresponding
MafB or MafB-CT.
Examination of the genomic islands revealed that mafAs
of phylogenetic group I are always immediately followed
by a mafB of group I, whilst islands containing a mafA of
group II always contain an adjacent mafB of group III
(Fig. 1). Remarkably, the mafB genes of group II
(NMBG2136_0582, NMC0586 and NMO_0529 of strains
G2136, FAM18, and Alpha14, respectively, in Fig. 1) are
not directly adjacent to a mafA, but they are located on an
island (MGI-2) usually also containing a mafA of group I
and a mafB of group I. Furthermore, the mafB-CTs only
share sequences with the upstream located mafB or mafBs
of the same phylogenetic group located on a different is-
land (see Fig. 1 for examples), suggesting the existence of
independent mafB/mafB-CT systems with genetic ex-
change between mafB and mafB-CTs being restricted to
each system.
Overall, this analysis revealed that Maf systems share
several genetic features with the TPS systems involved in
interbacterial competition. Accordingly, it is logical to
hypothesize that (i) MafB is a secreted protein with
growth-inhibitory properties, (ii) MafI proteins confer spe-
cific immunity against the toxic MafB, and (iii) mafB-CTs
represents a source of switchable toxic modules.
Characterization of MGIs in strain B16B6
To investigate our hypotheses, we used N. meningitidis
strain BB-1, an unencapsulated derivative of B16B6 of
Fig. 1 Organization of maf islands in various N. meningitidis genome sequences. Most islands contain a mafA, mafB (indicated by their locus tags)
and a variable repertoire of mafB-CTs interspersed with ORFs, called mafIs, which may encode immunity proteins (indicated with open arrows). It
is not clear whether all these intervenient ORFs are required to confer immunity against the toxin encoded by the upstream mafB or mafB-CT
gene. Islands are classified as MGI-1, MGI-2 and MGI-3 according to [10]. The phylogenic groups of the mafA and mafB genes as defined in Fig. 2
are also indicated. The genes flanking the islands are colored green. MGI-1 contains a mafA and mafB from clusters I and is flanked by anmk coding for
anhydro-N-acetylmuramic acid kinase and an ORF encoding a small peptide of 91 aa that shows high sequence similarity with the N terminus of the
iron-regulated RTX toxin FrpC. MGI-2 contains a mafB of cluster II and usually also a mafA and mafB of clusters I. This island is flanked by a proline tRNA
gene and trk encoding a potassium transport system. MGI-3 contains mafA and mafB genes of clusters II and III, respectively, and is flanked by genes
encoding UMP kinase (pyrH) and the putative signal peptide peptidase SppA. The mafB and mafB-CT genes can share sequence identities in their
central and 5’ regions, respectively (underlined), that are probably used for homologous recombination. These regions are specific for each mafB group,
which is indicated by the different colors of the underlining. The 3’ end of the mafB and mafB-CT genes corresponds to the toxic domain; it is
hypervariable as indicated by different colors. The mafIs remain associated with the 3’ end of the upstream mafB or mafB-CTs during genetic
rearrangements in the maf islands; therefore, they are colored accordingly. Often additional intervenient ORFs are also found behind the mafIs
(colored black); whether they also contribute to conferring immunity or have other functions (or no function at all) is not clear. The presence
of an IS4 transposase gene in MGI-2 of strain G2136 is also indicated. Disrupted genes are indicated with red slashes. Regions that share more
than 85 % of sequence similarity between two islands are indicated with grey shadows. ORFs indicated in this figure are based on genome
annotations and our own analysis
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the clonal complex cc11 [11], in which TpsA-mediated
growth-inhibitory activity was previously demonstrated
[4, 12]. Extensive PCR analysis and subsequent sequen-
cing of PCR fragments revealed that this strain contains
three MGI corresponding with islands MGI-1 (GenBank
accession number KR006907), MGI-2 (GenBank accession
number KR012999), and MGI-3 (GenBank accession
number KR006906) in other meningococcal genomes
(Fig. 3). Comparison of the genetic organization of the
MGIs of strains FAM18 and B16B6, which are both of
the same clonal complex (cc11), revealed considerable
differences (Fig. 3). The genetic composition of MGI-3
is similar in both strains, with > 99 % of sequence iden-
tity. However, comparison of islands MGI-1 and MGI-2
of both strains revealed complex rearrangements. In
MGI-2, the toxic domain encoded by the first mafB
gene (mafB1MGI-2) and the downstream mafI and mafC
genes differ between the two strains (Fig. 3). In con-
trast, the second mafB gene in this island (mafB2MGI-2)
contains a similar 3’ end in the two strains. However,
downstream of mafB2MGI-2 and its cognate mafI, there
are large differences in the mafB-CT and mafI content
of the two strains (Fig. 3), and the organization in this
part of island MGI-2 of strain B16B6 is actually very
similar to that of MGI-2 of cc8 strain G2136 (Fig. 1),
except that the IS4 transposase gene is lacking. In is-
land MGI-1, the 3’ end of the mafB of B16B6 is differ-
ent from that of FAM18 (Fig. 3) but similar to that of
the second mafB in MGI-2 of strain G2136 (locus tag
NMBG2136_0596; Fig. 1). After the cognate mafI, the
organization of mafB-CT and mafI genes in MGI-1 of
B16B6 is also deviant from that in FAM18 (Fig. 3) but
similar to that in the corresponding island of strain
MC58 (compare Figs 1 and 3).
The very different organization of the MGI-1 and
MGI-2 islands in cc11 strains B16B6 and FAM18 is
striking, since comparative analysis of the TPS island in
these strains and a large collection of other cc11 strains
evidenced only a very low frequency of genetic rear-
rangements [4]. To confirm the genetic variability of the
maf loci, we extended our analysis to available genome
sequences of nine other cc11 strains, i.e. ES14902,
M6190, M7124, NM3682, NM3683, NM126, M10208,
NM174 and NM82. In all these strains, the C terminal
toxic domains of MafB2MGI-2 and MafBMGI-3 are similar
to those of FAM18 and B16B6, whilst that of MafBMGI-1
is similar to that in B16B6 but different from that in
FAM18. In two strains, i.e. NM3682 and NM3683, the
toxic domain of MafB1MGI-2 is similar to that of B16B6,
while it is similar to that of FAM18 in the other seven
strains. Thus, these results suggest that the C-terminal
toxic domain of MafB of phylogenetic cluster III, which
is encoded by MGI-3, is rather stable in strains of the
same cc11 lineage, as previously found for TpsA [4],
but the MafBs of clusters I and II, which are encoded
by MGI-1 and MGI-2, seems to be more prone to
alteration.
MafB functions in meningococcal growth inhibition
To investigate the putative role of MafB proteins in medi-
ating growth inhibition, we first constructed several mu-
tants of strain BB-1, lacking diverse genes in different maf
Fig. 2 Phylogenetic trees of MafA and MafB proteins. For the construction of the trees, the amino-acid sequences of predicted mature MafA proteins
and the N-terminal DUF1020 domain of predicted MafB proteins of different meningococcal strains were compared. The genetic distances are indi-
cated with horizontal lines at the bottom
Arenas et al. BMC Microbiology  (2015) 15:156 Page 4 of 11
islands. These mutants were mixed with a rifampicin-
resistant derivative of the parent strain in different ratios
and the numbers of wild-type and mutant bacteria were
determined by plating on selective media at time 0 and
after different periods (3 –5 h) of co-incubation at 37 °C
while shaking. However, under these conditions, we did
not observe inhibition of the growth of the mutants rela-
tive to the parent. Therefore, we next performed these as-
says on GC plates in a candle jar, conditions that were
previously found to be optimal to detect TpsA-mediated
growth inhibition [4]. Under these conditions, growth of a
mutant lacking the complete MGI-3 island (ΔMGI-3; in-
dicated in blue in Fig. 4) and of a mutant lacking the
entire MGI-3 island except for mafA (data not shown)
were significantly reduced in the presence of the parent,
whilst that of a mutant lacking only mafA of MGI-3 was
not inhibited (ΔmafAMGI-3; indicated in black in Fig. 4).
When a mutant lacking mafB2 and all downstream
genes of island MGI-2 (ΔmafB2IB-CTsMGi-2; green in
Fig. 4), or a mutant lacking all genes except for mafA of
island MGI-1 (ΔmafBIB-CTsMGI-1; red in Fig. 4), were
tested in similar conditions, no significant growth in-
hibition by the parent was detected. These results dem-
onstrate that at least island MGI-3 mediates growth
inhibitory activities.
mafB and mafI genes encode toxins and cognate
immunity proteins
To investigate whether indeed the C-terminal part of
MafBMGI-3 is responsible for the growth-inhibitory effect
observed in the in vivo assays, we cloned the DNA for
this fragment from strain B16B6 with a FLAG-epitope
tag into a pAYC184-derived vector behind an arabinose-
inducible promoter. Although we did not detect growth
inhibitory activity in vivo of the MafBs of phylogenetic
cluster I encoded by islands MGI-1 and MGI-2, we
decided to clone also, as a representative, the DNA for
the C-terminal fragment of MafB2MGI-2 to investigate
whether also this protein is a toxin. It is noteworthy that
this domain is recognized in the Conserved Domain
Database (CDD) as a toxin64 domain with a possible
RNase function. In contrast, the C-terminal domain of
MafBMGI-3 of B16B6 was not recognized in CDD as a
putative toxic domain, but it was predicted to be a
toxin_56 (putative RNase) with 95 % probability using
the HHpred server. We also cloned the mafIs located
immediately downstream of these mafBs on the chromo-
some into a pET26b vector behind an isopropyl-β-D-1-
thiogalactopyranoside (IPTG)-inducible T7 promoter;
the resulting recombinant proteins contain a His6 tag on
their C-terminal end. The plasmids were introduced in
Fig. 3 Genetic organization of the MGI of strain B16B6. B16B6 contains three MGIs. The genetic composition of each island and their flanking
regions (indicated by solid green arrows) are in accordance with those observed in other genomes (Fig. 1); therefore, the same classification is
applied. The different genomic features of each island are illustrated as indicated in the legend to Fig. 1. Color coding of genes is also similar as
in Fig. 1. The organization of the MGI of strain B16B6 is compared with those of FAM18, which is of the same clonal complex cc11; similarities are
indicated with grey shadowing as in Fig. 1. MGI-3 of FAM18 is similar to that of B16B6 and is therefore not depicted. DNA fragments targeted by
PCR for the generation of knockout constructs are indicated by lines and numbered a-h; the corresponding primers are presented in Additional
file 1: Table S1
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E. coli strain BL21 (DE3). The expression of the recom-
binant proteins was independently controlled with spe-
cific inducers and tested by Western blotting, and cell
viability after overnight induction was tested by plating
the bacterial suspensions on LB plates with appropriate
antibiotics. The expression of the C-terminal fragment
of MafB2MGI-2 in E. coli resulted in a drastic reduction
of cell viability compared to the non-induced control
(Fig. 5a). Viability was restored when the cognate
MafI2MGI-2 was co-expressed, but not by co-expression of
MafIMGI-3. Similarly, the expression of the C-terminal part
of MafBMGI-3 resulted in a drastic reduction of cell via-
bility, which could be restored by co-expression of the
cognate MafIMGI-3 but not of the non-cognate MafI2MGI-2
(Fig. 5a). These assays confirmed that indeed the
C-terminal parts of both MafBs are toxic and that their
activity is specifically inhibited by the cognate MafI.
Usually, the immunity proteins of toxin-antitoxin sys-
tems confer protection through their direct interaction
with the cognate toxins. To investigate whether the MafI
proteins interact with the C-terminal fragments of the
corresponding MafBs, pull-down assays were performed.
The His-tagged immunity proteins were purified on Ni2+
beads from E. coli cells also expressing the C-terminal
MafB fragments, and the co-purification of the MafB frag-
ments was examined on Western blots. As anticipated,
both MafB2MGI-2 and MafBMGI-3 C-terminal fragments
were purified together with their cognate immunity
proteins but not with non-cognate MafI (Fig. 5b). Thus,
these assays confirmed the role of MafI in conferring
protection by specifically interacting with C-terminal
domain of the cognate MafB.
Discussion
Toxins play an important role in the competition
between bacteria for limited resources. They are pro-
duced to inhibit the growth of competitors for the same
niche and, in addition, they are used for self recognition
in a bacterial community. Bacteria have developed sev-
eral independent competition systems, including bacte-
riocins, TPS systems, type 6 secretion systems, Rhs, or
the ESX systems in Gram-positive bacteria [13–15]. The
neisserial Maf systems appear to share features with sev-
eral of these previously characterized competition sys-
tems. Growth inhibition in these systems is mediated by
a cell-surface-exposed or secreted protein, i.e. MafB in
the case of the Maf system. Like in many other systems,
the C-terminal end of MafB contains a polymorphic
toxic module, whilst the rest of the protein might be
required for its secretion and/or for its interaction with
receptors on the target cells. Producing cells are pro-
tected against the toxic activity by a small protein, i.e.
MafI in the Maf system, which interacts with the toxin
and is usually encoded by the gene immediately adjacent
to the toxin gene. Like in several other systems, the
mafB and mafI genes are located on genetic islands to-
gether with a variable repertoire of genes putatively en-
coding N-terminally truncated toxins, called mafB-CTs
in the Maf system [10], with the cognate immunity
genes. By genetic rearrangements, these mafB-CTs may
substitute the 3’ end of the mafB gene, thereby replacing
its toxic activity, whilst the array of encoded immunity
proteins may confer protection against a variety of toxins
that may be encountered in the natural habitat. Indeed, a
variety of toxic domains may be encoded at the 3’ end of
the same mafB gene in different genomes, and the same
domains may be found at the 3’ end of mafB-CT genes in
other genomes (Fig. 1), clearly supporting the idea that
such rearrangements occur in vivo. The substitution of
the toxic module may offer a selective advantage in a
given bacterial community [4, 16] but may also lead to the
loss of immunity genes [4]. Indeed, an analysis of the fre-
quency of substitution of toxic domains in the tpsA loci of
N. meningitidis evidenced that this event occurs but is
very rare in isolates of the same genetic lineage and that
such alteration may generate a competitive disadvantage
relative to other members of the community [4]. Similarly,
our analysis of a limited set of strains of the same genetic
lineage in the current study evidenced no alterations at
the C terminus of MafB proteins of phylogenetic group III
encoded on MGI-3. However, rearrangements were evi-
dent in MafB proteins of phylogenetic groups I and II
encoded on MGI-1 and MGI-2. Note that the mutual
similarity between MafB proteins of groups I and II is
Fig. 4 Growth inhibition assays. Cells of a rifampicin-resistant derivative
of BB-1 were mixed 1:1 with cells of mutant strains ΔmafAMGI-3, lacking
mafA of MGI-3, ΔmafB2IB-CTsMGI-2, lacking mafB2 and all downstream
genes of MGI-2, ΔmafBIB-CTsMGI-1, lacking mafB and all downstream
genes of MGI-1, or ΔMGI-3,lacking the entire MGI-3 island, all carrying a
kanamycin-resistance cassette. The suspensions were spotted on GC
plates without antibiotics and incubated for 48 h. The ratios of the
mutants over wild-type bacteria in the spots were determined by
plating on GC media containing kanamycin or rifampicin and
counting colony-forming units after overnight incubation. Results
are means and s.d. of three independent experiments. Statistically
significant differences between time 0 and 48 h are marked with
an asterisk (unpaired t-test of P < 0.001). All strains tested here did
not show differences in viability when grown separately
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higher than their similarity to group 3 (Fig. 2). It is con-
ceivable that MafBMGI-3 plays a role in the maintenance of
the bacterial community, while MafB proteins encoded on
MGI-1 and MGI-2 may offer a selective advantage to
members of a community only under specific conditions.
Perhaps, this may explain why we detected growth inhibi-
tory activity only of MafBMGI-3 and not of MafBMGI-1 and
MafB2MGI-2. Possibly, the latter MafB proteins or their
cognate receptors on the target cells are not expressed
under the experimental conditions used. Alternatively,
these proteins may target other bacterial species or
eukaryotic cells. This question remains to be elucidated in
future work.
The secretion mechanism of MafB was not elucidated
in this work. MafB proteins were detected in the culture
supernatant of N. meningitidis strain when overex-
pressed from a plasmid but the secretion mechanism
was not solved [10]. MafB proteins are synthesized with
an N-terminal signal sequence for transport across the
inner membrane via the Sec system. Furthermore, all
mature MafB proteins contain a conserved DUF2010 do-
main at their N-terminal end, which may constitute a
recognition signal for the machinery that mediates its
subsequent transport across the outer membrane. The
MafA proteins, previously reported to function as
glycolipid-binding adhesins [17], are likely candidates to
constitute this machinery. Interestingly, our phylogenetic
analysis revealed two main clusters of MafA variants,
which paralleled the clustering of the MafB proteins into
two main clusters based on their DUF1020 domains, sug-
gesting specificity in the recognition of MafB proteins by
the cognate MafA. However, MafA is a predicted lipopro-
tein and secondary structure predictions were inconsistent
with a β-barrel conformation, which is common among
integral outer membrane proteins, including, for example,
the TpsB proteins, which mediate the transport of TpsA
proteins across the outer membrane in the TPS systems
[1]. Perhaps, the quaternary structure of MafA generates a
channel in the outer membrane as reported, for example,
for the CsgG protein, which mediates the translocation of
curli subunits across the outer membrane [18].
Some MafB proteins contain a Hint domain in be-
tween the DUF1020 domain and the toxic domain.
Such domains are responsible and sufficient for protein
splicing and could have a role in toxin processing and
delivery into the target cells. There are two types of
Hint domains, designated type A and B, based on se-
quence motifs [19]. The Hint domains, if present in
MafB proteins, are of type A. Proteins containing this
domain undergo splicing and release of the C-terminal
part [19]. However, most MafB proteins do not contain
such a Hint domain; how the C-terminal toxic moiety
is released and transported into the target cells in those
cases is not clear and remains to be investigated.
Whilst this manuscript was in preparation, an independ-
ent study reported the toxic activity of the C-terminal
domains of some of the MafB proteins of another menin-
gococcal strain, 8013, and the competitive advantage of
overexpression of one of these MafB proteins [10], con-
sistent with the observations reported in this paper.
Conclusions
In this work, we identified the neisserial MafB proteins
as a novel family of toxic proteins involved in interbac-
terial competition. We demonstrated that the toxic ac-
tivity of MafB of strain B16B6 resides in the C-terminal
region, while MafI specifically interacts with this toxic
domain to confer protection to the producing cells. Fur-
ther studies will be directed to elucidate the secretion
mechanism of MafB and to identify possible applications
of this system to fight pathogens.
Methods
Bioinformatics analysis
The C-terminal 150 aa of several meningococcal TpsA
and TpsC proteins present in available genome se-
quences were used as input queries in BLAST searches.
Analysis and comparisons of DNA and protein se-
quences were performed with Clone Manager software
Suite 7. Alignment of protein sequences was performed
in MAFFT version 7 (http://mafft.cbrc.jp/alignment/server/).
Aligned sequences were then used for phylogenetic
analyses using the Neighbour-joining method with the
available MEGA software version 6 (http://www.megasoft
ware.net/). The matrices and phylogenetic trees derived
from this study were deposited in Treebase repository
(http://treebase.org/treebase-web/search/study/anyObjectAs
RDF.rdf?namespacedGUID=TB1:S17890). The subcellular
(See figure on previous page.)
Fig. 5 MafB and mafI genes code for toxins and cognate immunity proteins, respectively. a The recombinant C-terminal, putatively toxic domains
(TD) of MafB2MGI-2 and MafBMGI-3 and the immunity proteins MafI2MGI-2 or MafIMGI-3 of strain B16B6 were expressed in E. coli strain BL21 (DE3) and
survival was determined. Expression of the MafB TD fragments was induced or repressed with arabinose or glucose, respectively, as indicated on top
of the figure and expression of the mafI genes was induced with IPTG when the corresponding plasmids were present. After overnight incubation,
20 μl of the bacterial suspensions were spread on half of an LB agar plate containing appropriate antibiotics, and the plates were incubated overnight
at 37 °C. b MafI specifically interacts with the C-terminal TD of the cognate MafB. BL21 (DE3) cells co-expressing a Flag-tagged C-terminal MafB TD and
a His-tagged MafI were disrupted by sonication, and the lysate was mixed with Ni2+ NTA resin. Aliquots of resin-bound and unbound fractions were
analyzed by Western blotting with anti-Flag and anti-His monoclonal antibodies
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localization of proteins was predicted using the servers
SignalP (http://www.cbs.dtu.dk/services/SignalP/) and LipoP
(http://www.cbs.dtu.dk/services/LipoP/). Secondary and ter-
tiary structure of the mature proteins were predicted using
the public web-based programs Phyre2 (http://www.sbg.bio.
ic.ac.uk/phyre2/html/page.cgi?id=index) and PSIPRED v3.3
(http://bioinf.cs.ucl.ac.uk/psipred/). For homology detec-
tion, the HHpred server was used at http://toolkit.tuebin
gen.mpg.de/hhpred.
Bacterial strains and growth conditions
N. meningitidis strain BB-1 is a non-capsulated deriva-
tive of strain B16B6 of clonal complex cc11 [11]. A
spontaneous rifampicin-resistant mutant of BB-1 was
also described [11]. The bacteria were grown at 37 °C
on GC medium base (Difco) supplemented with Isovita-
leX (Becton Dickinson) and appropriate antibiotics
(100 μg ml−1 of kanamycin, 5 μg ml−1 of chloramphenicol,
or 50 μg ml−1 of rifampicin) at 37 °C in a candle jar. For li-
quid cultures, bacteria grown on plates were diluted in
tryptic soy broth (TSB; Beckton Dickinson) to an OD550
of 0.1 and incubated in 25-cm2 polystyrene cell-culture
flasks with constant shaking at 110 rpm.
E. coli strains DH5α and BL21 (DE3) (Invitrogen) were
grown in lysogeny broth (LB) or LB agar at 37 °C. When
required, the media were supplemented with antibiotics
(100 μg ml−1 of kanamycin, 25 μg ml−1 of chlorampheni-
col, or 10 μg ml−1 of tetracycline).
PCR amplification and sequencing
Chromosomal DNA was extracted from BB-1 and its
mutant derivatives as described [4] and used as template
DNA for PCRs. PCRs were performed using 1–2 μl of
extracted DNA, 200 μM dNTPs (Fermentas), 0.25 μM of
different primer combinations (see in Additional file 1:
Table S1), 0.5 U of Expand High Fidelity Enzyme Mix,
and PCR buffer of the Expand High Fidelity PCR System
(Roche). Thermal cycling conditions were 30 cycles of
1 min at 95 °C, 0.5 min at 58 °C and elongation at 72 °C
during 1 min per kbp of expected amplicon size. Reac-
tions were preceded by incubation at 95 °C for 10 min
and terminated with an extended elongation step for
10 min at 72 °C. The PCR products were separated by
electrophoresis in 1 % agarose gels and stained with eth-
idium bromide for visualization. Some PCR products
were cloned into the pCR2.1-TOPO vector (Invitrogen),
according to the manufacturer’s instructions. Plasmids
and PCR products were purified using the Plasmid Ex-
traction kit and Clean-Up System, respectively, (Pro-
mega). Purified plasmids and PCR products of variable
length were sequenced at the Macrogen sequencing
service (Seoul, Korea). For sequencing the maf islands,
several overlapping DNA fragments were amplified by
PCR, and then sequenced either directly or after cloning
in the TOPO vector using internal primers. Amplification
reactions were carried out independently and repeated at
least twice for each fragment. Assembly of sequences was
performed with SeqMan II software (DNAstart Inc.).
DNA manipulation techniques
Cloning was performed in E. coli DH5α. All primers
used for PCR amplifications with the restriction sites
they contain are listed in Additional file 1: Table S1. To
generate knockout constructs, DNA fragments upstream
and downstream of the gene (s) of interest were ampli-
fied from chromosomal DNA of strain B16B6 as indi-
cated in Fig. 3. PCR products were purified, digested
with proper restriction enzymes, and sequentially cloned
into pnhbA::kan [4] thereby replacing DNA fragments
flanking the kanamycin-resistance cassette in the ori-
ginal plasmid. The knockout constructs were purified
and used to transform strain B16B6. Appropriate PCRs
were used to verify the presence of the correct muta-
tions in kanamycin-resistant transformants.
For expression of recombinant proteins in E. coli,
DNA fragments corresponding to the toxic regions (the
C-terminal 100 aa residues) of the MafB proteins
MafB2MGI-2 and MafBMGI-3 and the cognate MafI pro-
teins of BB-1 were amplified by PCR. The mafI genes
were cloned into the expression vector pET26b behind a
T7 promoter, which is inducible with IPTG and re-
pressed with glucose. Cloning in this vector resulted in a
6xHis-tag at the C terminus of the recombinant protein.
The mafB gene fragments were cloned behind the
arabinose-inducible araBAD promoter (PBAD) on a
pACYC184-derived vector. This vector was prepared by
amplifying PBAD together with the downstream yciM-
phoA chimeric gene from plasmid pBADyciM-phoA
[20] and cloning the resulting PCR product into the
chloramphenicol-resistance gene on pACYC184 [21],
resulting in plasmid pACYC184-PBAD-yciM-phoA. The
mafB fragments were substituted for the yciM-phoA
chimeric gene on pACYC184-PBAD-yciM-phoA. The clon-
ing procedure resulted in the presence of an N-terminal
FLAG tag in the recombinant proteins. To avoid the lethal
effect of the production of the toxic MafB fragments, the
plasmids encoding these fragments were introduced in
DH5α and BL21 (DE3) under repression conditions (i.e. in
the absence of arabinose and the presence of 2 % glucose),
and when necessary, the expression of the cognate MafI
from a plasmid in trans was induced. The correct expres-
sion of recombinant proteins was determined by Western
blotting.
Growth inhibition assays
For growth inhibition assays, the rifampicin-resistant de-
rivative of BB-1 was used as the killer and various maf
mutant derivatives of BB-1 containing a kanamycin-
Arenas et al. BMC Microbiology  (2015) 15:156 Page 9 of 11
resistance marker as target cells. Growth inhibition was
performed as described [4, 12]. Briefly, bacteria from
overnight cultures were grown independently in TSB for
4–5 h. Strains were then mixed 1:1 in TSB and drops
were spotted on GC medium plates and incubated for
48 h at 37 °C in candle jars in a humid atmosphere. Sub-
sequently, bacteria were scraped from the plates, resus-
pended in TSB, and the ratio of the different bacteria at
time 0 and after 48 h of co-incubation was determined
by plating on selective GC plates containing either ri-
fampicin or kanamycin and counting colonies after over-
night incubation. Data of three independent experiments
performed in duplicate were considered for statistical
comparisons using an unpaired statistical t-test.
Toxicity in E. coli and pull-down assays
E. coli BL21 (DE3) harboring plasmids carrying the 3’
end of mafB and mafI genes were used for toxicity as-
says. Bacteria from overnight cultures were diluted to an
OD600 of 0.1 in 10 ml of LB with appropriate antibiotics
for plasmid selection. The concentrations of glucose (0.5
or 2 %), arabinose (2 %) and IPTG (0.1 or 1 mM) used
for repression or induction of protein synthesis were opti-
mized for each strain. After overnight incubation, bacteria
were plated on LB plates containing proper antibiotics for
determination of cell viability. The assays were repeated at
least three times. Plates of a representative experiment
were photographed with a conventional camera.
For pull-down assays, recombinant MafB and MafI pro-
teins were simultaneously overproduced and the His-
tagged MafI was purified by affinity chromatography using
Ni2+-NTA beads (QIAGEN GmbH, Hilden) according to
the manufacturer’s instructions. Briefly, bacteria were
lysed by sonication in 50 mM sodium phosphate, pH 8.0,
300 mM sodium chloride, and 10 mM imidazole, and cell
debris was removed by centrifugation (6000 g, 30 min).
The supernatant was mixed with Ni2+ beads, and the
beads were washed with 50 mM sodium phosphate,
pH 8.0, 300 mM sodium chloride, 20 mM imidazole, and
eluted with the same buffer containing 250 mM imidazole.
The correct purification of the His-tagged MafI and the
co-purification of the FLAG-tagged MafB were examined
by SDS-PAGE and Western blotting.
Sample preparation, SDS-PAGE and Western blotting
For sample preparation, cultures were adjusted to an
OD600 of 1.0, and cells were collected by centrifugation
(8000 rpm during 3 min, Eppendorf Centrifuge 5424) and
suspended in sample buffer. Purified proteins eluted from
Ni2+ beads were mixed with double-strength sample buf-
fer. SDS-PAGE was performed at 200 V during ∼ 45 min
in a discontinuous buffer system using 12 % or 15 % poly-
acrylamide gels. Gels were stained with Coomassie bril-
liant blue G250 or the proteins were transferred to
nitrocellulose membranes. Membranes were subsequently
blocked with PBS containing 0.1 % (v/v) Tween 20 (PBST)
and 0.5 % (w/v) non-fat dried milk (PBST-M) for 1 h and
incubated with anti-His (Thermo Fisher Scientific) or
anti-FLAG monoclonal antibodies in PBST-M for 1 h at
room temperature. After washes with PBST, the mem-
brane was incubated for 1 h with horseradish peroxidase-
conjugated goat anti-mouse immunoglobulins diluted in
PBST-M. After extensive washing in PBST, blots were de-
veloped with the Pierce ECL Western blotting substrate.
Additional file
Additional file 1: Table S1. Primers used in this study. (PDF 256 kb)
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